Burd A, Levine RL, Shoben A, et al. Initial Report of the Beat AML Umbrella study for previously untreated AML: evidence of feasibility and early success in molecularly driven phase 1 and 2 studies. ASH Annual Meeting and Exposition 2018, abstract 559.
Obinutuzumab- versus rituximab-immunochemotherapie bij eerder onbehandeld iNHL
okt 2023 | Immuuntherapie, Lymfoom